Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4844656

O=C(O)C(F)(F)F.Oc1ccccc1-c1nc2cc(Br)cnc2[nH]1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.47
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
GUSB P08236 2/20 0.44
PAX8 Q06710 1/20 0.41
HSD17B10 Q99714 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
PDE5A O76074 3/20 0.38
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37
PLAT P00750 1/20 0.37
HPN P05981 1/20 0.37
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4841890 0.88 PTGES (0.46) PTGESHPGDHDAC3HDAC7HDAC10
Trifluoroacetic Acid SCHEMBL4843458 0.85 PDE5A (0.43) GUSBHSD17B10HDAC6PDE5ACCNB2
SCHEMBL4844661 0.80 PDE5A (0.37) PTGESGUSBHDAC3HDAC7HDAC10
Trifluoroacetic Acid SCHEMBL4843644 0.79 PIN1 (0.49) HDAC3HDAC6MGAM
Trifluoroacetic Acid SCHEMBL5260040 0.77 ALDH1A1 (0.48) KDM4EHPGDHSD17B10HDAC6ALDH1A1
SCHEMBL13607846 0.76 PTGES (0.55) PTGESHPGDHDAC6MGAMCDK1
Trifluoroacetic Acid SCHEMBL4841475 0.76 DYRK1B (0.38) HDAC6CCNB2CDK1CCNB1GSK3B
Trifluoroacetic Acid SCHEMBL4834909 0.76 HDAC6 (0.47) KDM4EHPGDHDAC3HDAC6ALDH1A1
Trifluoroacetic Acid SCHEMBL4842729 0.76 AURKA (0.52) KDM4EGUSBCCNB2CDK1CCNB1
Trifluoroacetic Acid SCHEMBL4842876 0.76 CHEK2 (0.45) KDM4EGUSBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 PTGES 1862/4885KDM4E 2903/4885HPGD 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.